A Letter from JOINN
2020-02-02
Dear R&D enterprises and colleagues,
During the special period of national prevention and control of "Novel coronavirus epidemic", JOINN earnestly implemented the national and local policies to extend the Spring Festival holiday, and each subsidiary company referred to the resident policy documents for implementation.
During the Spring Festival, JOINN arranged more than 300 resident employees (local people or employees not went home for the holidays and not left the local area) to work overtime to ensure that the ongoing trial is not affected. At the same time, the company has formulated scientific, strict and feasible epidemic prevention and control systems and measures to ensure the personal safety of employees.
Since the outbreak, many R&D enterprises are working overtime to develop drugs against novel Coronavirus (nCoV). As the most complete platform for non-clinical drug evaluation in China, JOINN, together with R&D enterprises, undertook the drug evaluation work against novel Coronavirus. JOINN's non-clinical facilities, including traditional animal rooms, biosafety Level 2+ (ABSL2+) animal rooms (large and small animals), and BSL2+ testing laboratory, have been working continuously to accelerate the research and development of anti- nCoV drugs in order to fight the epidemic.
All the employees of the company promise to open a green channel for the research and development of drugs against Novel Coronavirus (nCoV), fully mobilize resources, and complete the evaluation work with the fastest speed and the highest efficiency.
We would like to pay tribute to the frontline workers fighting the epidemic. Hats off to drug developers! Salute the dedicated Employees of JOINN!
Wish you all good health! Wish safe and effective drugs can be developed as soon as possible!